| Literature DB >> 31551171 |
Kazutoshi Ebisawa1, Yosuke Masamoto1, Junji Koya1, Arika Shimura1, Aya Shinozaki-Ushiku2, Kazuhiro Toyama1, Kumi Nakazaki1, Mineo Kurokawa3.
Abstract
Entities:
Keywords: CD30 positive lymphoma; Refractory lymphoma; Salvage treatment; Targeted therapy
Year: 2019 PMID: 31551171 DOI: 10.1016/j.clml.2019.08.017
Source DB: PubMed Journal: Clin Lymphoma Myeloma Leuk ISSN: 2152-2669